• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CRYOLIFE, INC. BIOGLUE SYRINGE 5-PACK, 10 ML, JAPAN; GLUE,SURGICAL,ARTERIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CRYOLIFE, INC. BIOGLUE SYRINGE 5-PACK, 10 ML, JAPAN; GLUE,SURGICAL,ARTERIES Back to Search Results
Model Number BG3510-5-J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Type  Injury  
Event Description
According to the publication, surgical glue-induced left main trunk stenosis removed by directional coronary atherectomy: a (b)(6) man underwent aortic repair for acute aortic dissection.The pseudolumen of the valsalva sinus was reapproximated with bioglue by placing a sponge inside of it to prevent the bioglue from entering.Postoperative contrast-enhanced computed tomography showed stenosis of the left main trunk.Directional coronary atherectomy was performed; complete release of the stenosis was achieved.Various fragments retrieved from the left main trunk were pathologically consistent with bioglue.When we reapproximated the dissected aortic wall, inserting a sponge into the aorta did not prevent the surgical glue from entering.Directional coronary atherectomy was a good therapeutic option to treat glue-induced coronary artery stenosis.
 
Event Description
According to the publication, surgical glue-induced left main trunk stenosis removed by directional coronary atherectomy: a 55-year-old man underwent aortic repair for acute aortic dissection.The pseudolumen of the valsalva sinus was reapproximated with bioglue by placing a sponge inside of it to prevent the bioglue from entering.Postoperative contrast-enhanced computed tomography showed stenosis of the left main trunk.Directional coronary atherectomy was performed; complete release of the stenosis was achieved.Various fragments retrieved from the left main trunk were pathologically consistent with bioglue.When we reapproximated the dissected aortic wall, inserting a sponge into the aorta did not prevent the surgical glue from entering.Directional coronary atherectomy was a good therapeutic option to treat glue-induced coronary artery stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE SYRINGE 5-PACK, 10 ML, JAPAN
Type of Device
GLUE,SURGICAL,ARTERIES
Manufacturer (Section D)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer (Section G)
CRYOLIFE, INC.
1655 roberts blvd., nw
kennesaw GA 30144
Manufacturer Contact
rochelle maney
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key12819840
MDR Text Key281999794
Report Number1063481-2021-00037
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberBG3510-5-J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date10/20/2021
Initial Date Manufacturer Received 10/20/2021
Initial Date FDA Received11/16/2021
Supplement Dates Manufacturer Received10/20/2021
Supplement Dates FDA Received01/19/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age55 YR
Patient SexMale
-
-